Substance Use in Outpatient Therapy: A Clinical Framework
By Kristen McClure, MSW, LCSW | TherapistWorksheet.com
Most therapists will work with clients who have substance use concerns — whether or not “addiction” is the presenting problem. Understanding how to approach substance use clinically, without moralism or oversimplification, makes you a more effective clinician across your entire caseload.
The Modern Framework: Substance Use Disorder
DSM-5 replaced the previous abuse/dependence distinction with a single Substance Use Disorder diagnosis on a severity spectrum (mild, moderate, severe). The criteria cluster around: impaired control, social impairment, risky use, and pharmacological criteria (tolerance, withdrawal). Understanding the severity spectrum matters for treatment intensity decisions.
Substance use is not a moral failing. It is a complex condition with genetic, neurological, developmental, and environmental contributions. Treating it as a character or willpower problem produces shame, which reliably makes it worse.
Harm Reduction vs. Abstinence: Both Have a Place
The abstinence vs. harm reduction debate is often false. Most clinicians use both frameworks depending on the client, the substance, the severity, and what the client is ready for.
Harm reduction — meeting clients where they are, reducing consequences of use without requiring cessation as a precondition for treatment. Evidence-supported for a wide range of presentations.
Abstinence-based approaches — appropriate when: the substance use is severe, harm reduction has failed, the client is in recovery and has chosen abstinence, or the substance (e.g., alcohol with severe physical dependence) requires medical management of withdrawal.
The clinical stance: follow the client, not the ideology. What is the client’s relationship to their use? What are they able and willing to do? What would reduce their suffering and improve their functioning?
Motivational Interviewing as the Foundational Approach
MI is the most evidence-supported approach for substance use treatment — particularly for clients in contemplation or pre-contemplation. The goal is not to convince the client to change. It is to evoke their own ambivalence and motivation. Evoking change talk while not reinforcing sustain talk is the core clinical skill. (See the full MI guide for technique detail.)
Screening and Brief Intervention
SBIRT (Screening, Brief Intervention, and Referral to Treatment) is a public health framework now widely used in primary care and increasingly in behavioral health settings.
- Screening — AUDIT-C (alcohol), DAST-10 (drugs), or CAGE-AID are brief validated screens
- Brief Intervention — for low-to-moderate risk: motivational conversation, personalized feedback, goal-setting
- Referral to Treatment — for high risk or severe SUD: referral to specialized treatment (IOP, residential, MAT programs)
When to Refer for Specialized Treatment
- Severe alcohol use disorder — withdrawal can be medically dangerous (seizures, delirium tremens). Medically managed detox is required before residential treatment.
- Opioid use disorder — medication-assisted treatment (buprenorphine, methadone, naltrexone) has the strongest evidence. Refer to MAT-prescribing providers.
- Any substance use disorder that is not responding to outpatient individual therapy
- When co-occurring psychiatric conditions complicate the picture beyond your scope
Working with Relapse
Relapse is a common part of the recovery process — not a sign of treatment failure or client failure. The clinical response to relapse: assess what happened, what the client learned, what support is needed, and whether the level of care needs adjustment. Shame and punishment responses to relapse reliably make things worse.
“I want to understand what happened. Not to judge it — relapse is part of how this often goes. What can we learn from it about what you need?”
Frequently Asked Questions
Should I drug test my clients in outpatient therapy?
Drug testing in outpatient private practice is uncommon and raises clinical and ethical questions. In structured outpatient settings or when safety is a concern, it may be appropriate. The clinical utility and relational impact should be considered before making it part of a treatment protocol.
What about marijuana — is it a significant clinical issue?
Cannabis use disorder is a real diagnosis, and cannabis use is clinically significant when it interferes with functioning, mental health, or the goals of treatment. The shift in legal status and cultural normalization makes it harder for clients to see problematic use. Assess function and impact, not just use frequency.
My client is using substances to cope with trauma. Should I treat the trauma or the substance use first?
Increasingly, the evidence supports integrated treatment rather than sequential. Treating trauma and substance use concurrently (e.g., Seeking Safety, COPE) tends to produce better outcomes than waiting for sobriety before addressing trauma. Consult and consider referral to an integrated treatment specialist if this is new territory for you.
What do I say when a client is in active use and doesn’t see it as a problem?
Stay curious. Explore their relationship to the use, the role it plays, the costs they have noticed, and any ambivalence. Reflecting ambivalence and evoking their own reasons for change — even small ones — is the intervention. Lecturing or persuading typically produces reactance and more sustain talk, not less.
Kristen McClure, MSW, LCSW is a licensed therapist who creates practical clinical tools to help therapists navigate the hardest moments in their work.
